Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors
Akiyoshi Nakayama(National Defense Medical College), Nariyoshi Shinomiya(National Institute of Infectious Diseases), Yuka Shichijo(National Defense Medical College), Rieko Okada(Nagoya City University), Tappei Takada(University of Tokyo Hospital), Kenji Wakai(Japanese Society for Dialysis Therapy), Yusuke Kawamura(National Defense Medical College), Kimiyoshi Ichida(Tokyo University of Pharmacy and Life Sciences), Junko Abe(National Defense Medical College), Masayuki Sakiyama(National Defense Medical College), Hiroshi Nakashima(Brigham and Women's Hospital), Hiroshi Suzuki(University of Tokyo Hospital), Hirotaka Matsuo(National Defense Medical College), Hirofumi Nakaoka(National Institute of Genetics), A Akashi(National Defense Medical College), Seiko Shimizu(National Defense Medical College), Yutaka Sakurai(National Defense Medical College), Sayo Kawai(Nagoya University), Takahiro Nakamura(Kyoto University), Yuji Oikawa(Toho University), Yuzo Takada(National Defense Medical College), Takashi Tamura(Nagoya University), Tatsuo Hosoya(Jikei University School of Medicine), Toshinori Chiba(National Defense Medical College)
Cited by 96
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|690
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
|New England Journal of Medicine|2018|551
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|434
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia
|The American Journal of Human Genetics|2008|386